X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 56c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of $0.29, $0.56 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of $0.29, $0.56 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.